Medication info
Baropozireong 5/80 mg

Baropozireong 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201308583 · Approved 2013.07.31 · Insurance code 645604270

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
The safety and efficacy have not been established in pediatric patients under 18 years of age; therefore, use of this medicine is not recommended.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication helps lower and control blood pressure more effectively in patients with essential hypertension who are not adequately controlled on monotherapy with either amlodipine or valsartan alone. The two medications work in synergy to dilate blood vessels and maintain stable blood pressure, thereby reducing the risk of cardiovascular complications. Therefore, this medication is used for blood pressure management in patients with essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

The safety and efficacy have not been established in pediatric patients under 18 years of age; therefore, use of this medicine is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, therefore it must be discontinued immediately upon confirmation of pregnancy. Individuals with an allergy to this medication's active ingredients or similar medications, those who are pregnant or may become pregnant, nursing women, and those with severe kidney or liver diseases should not take this medication. Patients with sodium or fluid depletion, hyperkalemia, renal artery stenosis or kidney transplant recipients, patients with a history of angioedema, and those with heart failure or post-myocardial infarction patients should take this medication with caution under close medical supervision. Side effects such as dizziness, headache, edema, low blood pressure, gastrointestinal disturbances, skin rashes may occur during treatment, and any abnormal symptoms should be reported to a doctor immediately. Caution is needed when driving or operating machinery due to potential intermittent dizziness or fatigue during treatment. Drug interactions can occur when this medication is taken with other antihypertensive drugs, potassium supplements, or certain NSAIDs, so it's essential to inform your healthcare provider of any other medications being taken. It is recommended that pregnant or nursing women avoid using this medication, and it should also be avoided if planning to become pregnant. Safety and efficacy have not been established for pediatric patients, hence it is not recommended for use in children. In case of overdose, severe hypotension or heart-related issues may occur, so it is vital to adhere to the prescribed dosage, and seek immediate medical attention if any abnormal symptoms arise.

Side effects

Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, back pain, arthritis, muscle spasms, lethargy, frequency of urination, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, including hypersensitivity reactions related to serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitability, sensory loss, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best kept at room temperature between 1°C and 30°C. By storing it this way, the medication's effectiveness can be well maintained.

Appearance and packaging

Appearance

Dark yellow round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.